Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.28754 | 78 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.09296 | 76 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.27944 | 77 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.52189 | 78 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.52311 | 79 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.80418 | 75 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.27597 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.27692 | 77 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.26546 | 77 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.28104 | 77 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.27383 | 77 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.27354 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.27343 | 77 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.17468 | 77 |